All Roll Calls
Yes: 265 • No: 29
Sponsored By: Curtis Schomer (Republican)
Became Law
Personalized for You
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
3 provisions identified: 0 benefits, 3 costs, 0 mixed.
The law places several seizure and nerve‑pain drugs in Schedule V. These include lacosamide (Vimpat), pregabalin (Lyrica), gabapentin, ezogabine, brivaracetam, cenobamate, and ganaxalone. Salts and isomers are also covered. Doctors, pharmacies, and patients in Montana must follow Schedule V rules for making, prescribing, dispensing, and possessing these medicines.
The law sets when some combo medicines count as Schedule V. Codeine: no more than 200 mg per 100 ml or 100 g. Dihydrocodeine or ethylmorphine: no more than 100 mg per 100 ml or 100 g. Opium: no more than 100 mg per 100 ml or 100 g. Diphenoxylate: no more than 2.5 mg per dose and at least 25 micrograms of atropine per dose. Difenoxin: no more than 0.5 mg per dose and at least 25 micrograms of atropine per dose. The product must also include nonnarcotic active ingredients that add real medical effect. Amounts are calculated as the free anhydrous base or alkaloid and include salts. Makers, prescribers, pharmacists, and patients must follow Schedule V rules for these products in Montana.
The law adds two other drugs to Schedule V. Pyrovalerone is a Schedule V stimulant. Lasmiditan, a migraine medicine, is also in Schedule V. Salts and isomers are covered. Makers, prescribers, pharmacies, and patients in Montana must follow Schedule V rules for these drugs.
Curtis Schomer
Republican • House
Vince Ricci
Republican • Senate
All Roll Calls
Yes: 265 • No: 29
House vote • 2/15/2025
Do Concur
Yes: 46 • No: 2
House vote • 2/14/2025
Do Concur
Yes: 48 • No: 2
House vote • 1/20/2025
Do Pass
Yes: 85 • No: 13
House vote • 1/17/2025
Do Pass
Yes: 86 • No: 12
Chapter Number Assigned
Signed by Governor
Transmitted to Governor
Signed by President
Signed by Speaker
Returned from Enrolling
Sent to Enrolling
3rd Reading Concurred
2nd Reading Concurred
Committee Report--Bill Concurred
Committee Executive Action--Bill Concurred
Hearing
Referred to Committee
First Reading
Transmitted to Senate
3rd Reading Passed
2nd Reading Passed
Committee Report--Bill Passed
Committee Executive Action--Bill Passed
Hearing
First Reading
Referred to Committee
Introduced
Enrolled
3/14/2025
As Amended (Version 2)
2/17/2025
Introduced
12/9/2024